TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
2.430
-0.090 (-3.57%)
Nov 13, 2026, 4:00 PM EST - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $149.93 million as of November 13, 2026. It is the 22,290th most valuable company in the world and the 3,759th biggest in the United States. Its market cap has decreased by 31.98% in one year.
Market Cap
149.93M
Enterprise Value
142.56M
1-Year Change
-31.98%
Global Rank
Country Rank
#3,759 United States
Category
ChartMarket Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $149.93M, a decrease of -54.39%. That is a compound annual growth rate of -12.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 149.93M | -57.01% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RxSight | 221.39M |
| Electromed | 204.02M |
| Inogen | 149.51M |
| Quanterix | 143.38M |
| Owlet | 134.42M |
| Pulmonx | 129.78M |
| Apyx Medical | 126.37M |
| Neuronetics | 125.92M |